Tools
Llewelyn, Martin and Cohen, Jonathan (2001) Superantigen antagonist peptides. Critical Care, 5. pp. 53-55. ISSN 1364-8535
![]() |
PDF
- Published Version
Download (196kB) |
Official URL: http://dx.doi.org/10.1186/cc986
Abstract
The production of superantigenic exotoxins by Gram positive bacteria underlies the pathology of toxic shock syndrome. Future treatment strategies for superantigen-mediated diseases are likely to be directed at blocking the three-way interaction between superantigen, T cell receptor and major histocompatibility class II molecule, which inititates an excessive and disordered inflammatory response. In this article, we review the first published data to address one such strategy in the context of other recognised and experimental treatments.
Item Type: | Article |
---|---|
Schools and Departments: | Brighton and Sussex Medical School > Global Health and Infection |
Depositing User: | Sandy Gray |
Date Deposited: | 03 Oct 2016 11:16 |
Last Modified: | 02 Jul 2019 18:04 |
URI: | http://sro.sussex.ac.uk/id/eprint/63333 |
View download statistics for this item
📧 Request an update